Results
|
5101.
|
Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trial. [electronic resource] by
- Tejpar, Sabine
- Yan, Pu
- Piessevaux, Hubert
- Dietrich, Daniel
- Brauchli, Peter
- Klingbiel, Dirk
- Fiocca, Roberto
- Delorenzi, Mauro
- Bosman, Fred
- Roth, Arnaud D
Producer: 20190307
In:
European journal of cancer (Oxford, England : 1990) vol. 99
Availability: No items available.
|
|
5102.
|
|
|
5103.
|
|
|
5104.
|
|
|
5105.
|
CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissues. [electronic resource] by
- Guichard, S
- Terret, C
- Hennebelle, I
- Lochon, I
- Chevreau, P
- Frétigny, E
- Selves, J
- Chatelut, E
- Bugat, R
- Canal, P
Producer: 19990715
In:
British journal of cancer vol. 80
Availability: No items available.
|
|
5106.
|
Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer. [electronic resource] by
- Rocha Lima, Caio Max S
- Savarese, Diane
- Bruckner, Howard
- Dudek, Arkadiusz
- Eckardt, John
- Hainsworth, John
- Yunus, Furhan
- Lester, Eric
- Miller, William
- Saville, Wayne
- Elfring, Gary L
- Locker, Paula K
- Compton, Linda D
- Miller, Langdon L
- Green, Mark R
Producer: 20020405
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 20
Availability: No items available.
|
|
5107.
|
Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer. [electronic resource] by
- Stevenson, J P
- Redlinger, M
- Kluijtmans, L A
- Sun, W
- Algazy, K
- Giantonio, B
- Haller, D G
- Hardy, C
- Whitehead, A S
- O'Dwyer, P J
Producer: 20011204
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 19
Availability: No items available.
|
|
5108.
|
|
|
5109.
|
|
|
5110.
|
|
|
5111.
|
|
|
5112.
|
|
|
5113.
|
Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell line. [electronic resource] by
- Kohara, Hiroyuki
- Tabata, Masahiro
- Kiura, Katsuyuki
- Ueoka, Hiroshi
- Kawata, Kazuhiko
- Chikamori, Masakazu
- Aoe, Keisuke
- Chikamori, Kenichi
- Matsushita, Akio
- Harada, Mine
Producer: 20020411
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 8
Availability: No items available.
|
|
5114.
|
|
|
5115.
|
|
|
5116.
|
Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer. [electronic resource] by
- Machida, Nozomu
- Yoshino, Takayuki
- Boku, Narikazu
- Hironaka, Shuichi
- Onozawa, Yusuke
- Fukutomi, Akira
- Yamazaki, Kentaro
- Yasui, Hirofumi
- Taku, Keisei
- Asaka, Masahiro
Producer: 20081113
In:
Japanese journal of clinical oncology vol. 38
Availability: No items available.
|
|
5117.
|
|
|
5118.
|
A phase II study of cisplatin and irinotecan as induction chemotherapy followed by accelerated hyperfractionated thoracic radiotherapy with daily low-dose carboplatin in unresectable stage III non-small cell lung cancer: JCOG 9510. [electronic resource] by
- Fujii, Tomoki
- Kunikane, Hiroshi
- Okamoto, Hiroaki
- Watanabe, Koshiro
- Kunitoh, Hideo
- Mori, Kiyoshi
- Yokoyama, Akira
- Fukuda, Haruhiko
- Tamura, Tomohide
- Saijo, Nagahiro
Producer: 20100106
In:
Japanese journal of clinical oncology vol. 39
Availability: No items available.
|
|
5119.
|
|
|
5120.
|
Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients. [electronic resource] by
- Vincenzi, Bruno
- Santini, Daniele
- Loupakis, Fotios
- Addeo, Raffaele
- Rojas Llimpe, Fabiola L
- Baldi, Giacomo Giulio
- Di Fabio, Francesca
- Del Prete, Salvatore
- Pinto, Carmine
- Falcone, Alfredo
- Tonini, Giuseppe
Producer: 20091104
In:
Expert opinion on biological therapy vol. 9
Availability: No items available.
|